AU;Current Trials
  • Home
  • Clinical Trials
  • Obesity and T2DM Study Tauranga 38

Obesity and Type 2 Diabetes Mellitus Study

Tauranga

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming weight loss studies here.

Future Studies

Description

What to expect

Future Studies

Study details

Ages

18 to 75 years old

Duration

Approximately 48 weeks followed by a 5 week safety follow up. Regular clinic visits will be required

Compensation

You will be compensated

Eligibility Criteria

You may qualify if you:

  • Are 18 to 75 years old
  • Have Type 2 Diabetes Mellitus, diagnosed for at least 6 month
  • Are overweight with a BMI ≥ 25 – our medical team can access this for you
  • Are currently managing your diabetes with diet and exercise WITH/WITHOUT treatment with Metformin or a SGLT-2 inhibitor

 

You may not qualify if you:

  • Have Type 1 Diabetes
  • Have a history of weight loss surgery
  • Currently using injectable medications for T2DM control

 

Other eligibility criteria applies. A member of our team will check if this study is a good fit for you.

Locations

Tauranga

Description

Type 2 Diabetes Mellitus, or T2DM, is a long-term condition where the body can’t use insulin effectively. This causes high blood sugar levels. When combined with being overweight or obese, it increases the risk of serious health issues like heart disease, stroke, and kidney problems. 

Managing T2DM can be challenging. Even with healthy eating, exercise and medication, many people still struggle to keep their blood sugar in check or lose weight. Fatigue, hunger, and other daily symptoms can make it hard to maintain consistent progress in managing the condition.

This study is exploring a new weekly treatment that aims to help those with T2DM and excess weight better manage their blood sugar levels, support weight loss and improve overall health outcomes.

What to expect

Participants will be randomly assigned to receive a weekly dose of either the investigational medication or a placebo by subcutaneous (under the skin) injection. The investigational medication is designed to help improve blood sugar levels and support meaningful weight loss.

You will visit the clinic regular for health assessments and healthy lifestyle counselling. Your safety and well-being will be closely monitored by a professional clinical team. 

Why join this clinical research study?

- Gain early access to a new potential treatment at no cost

- Understand how to manage T2DM and obesity

- Contribute to advancing treatments for others

- Receive health checks and advice from our professional medical team

Your privacy is important. All personal information will be kept strictly confidential.

Register your interest today.

This study is now closed

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming weight loss studies here.

Weight Loss Studies
Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

WellingtonTaurangaHawke's BayKapitiPalmerston NorthLower HuttDunedinPukekohe AucklandPCRN Clinical Trial Sites

Australian locations

Fortitude Valley BrisbaneTaringa BrisbaneWellers Hill BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2025 © Momentum Clinical Research

Privacy Policy